Taaleri: Focus on the new flagship fund - Nordea
Detta är en aktieanalys producerad av tredje part och reflekterar därför nödvändigtvis ej våra åsikter och värderingar
Q2 will likely be negatively affected by market turbulence weighing on Garantia's investment operations, given high exposure to fixed-income products. However, the underlying development most likely remained favourable for both Garantia and private asset management. Q2 earnings will be supported by Ficolo earn-outs, while the focus should be on any new information about the new flagship SolarWind III fund. Taaleri's first bioindustry fund achieved its first closing in Q2 at a targeted EUR 80m and fundraising has continued. We derive a fair value range of EUR 11.0-12.5 (11.7-13.7) per Taaleri share.
Marketing material commissioned by Taaleri.
Marketing material commissioned by Taaleri.